Sanara Medtech Inc. entered into a Licensing and Distribution Agreement with Biomimetic Innovation Limited to exclusively market and distribute a synthetic bone filler in the U.S. and invested approximately $8 million for a 12.5% equity stake in BMI, with an initial investment of $3 million and a convertible loan of $1 million.